share_log

JMP Securities Maintains Market Outperform on TELA Bio, Lowers Price Target to $15

JMP Securities Maintains Market Outperform on TELA Bio, Lowers Price Target to $15

JMP Securities維持TELA Bio的市場跑贏大盤,將目標股價下調至15美元
Benzinga ·  2023/11/10 14:52

JMP Securities analyst David Turkaly maintains TELA Bio (NASDAQ:TELA) with a Market Outperform and lowers the price target from $20 to $15.

JMP Securities分析師戴維·圖爾卡利維持TELA Bio(納斯達克股票代碼:TELA)的股價跑贏大盤,並將目標股價從20美元下調至15美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論